• How shorter clinical trial processes prolong the lives of patients

  • Oct 20 2021
  • Duración: 29 m
  • Podcast

How shorter clinical trial processes prolong the lives of patients Por arte de portada

How shorter clinical trial processes prolong the lives of patients

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy.   In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss the use of technology in medicine and what makes an increase in the volume of clinical trials, including cgt clinical trials, and an acceleration of the clinical trial process significant.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre How shorter clinical trial processes prolong the lives of patients

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles